Recommended in Primary care oncology

  • Clinical Essentials from Carcinogenesis
  • 1 comment

Beauty at what cost? Hair product use linked to increased breast cancer risk

Dark hair dyes, relaxers in particular linked to increased risk.

Read more
  • Clinical Essentials from Eur Urol
  • 1 comment
  • FULLTEXT

Prostate cancer screening: what is the best approach?

Read more
  • Clinical Essentials from Oncotarget
  • 1 comment
  • FULLTEXT

Breast cancer prevention: long-term, frequent use of aspirin has protective effect

Read more
  • Clinical Essentials from J Cancer Surviv
  • 1 comment

Stage I-III breast cancer: exercise reduces premenopausal bone loss

Read more
  • Clinical Essentials from JAMA Intern Med
  • 1 comment

CRC: meta-analysis supports diagnostic FIT in high-risk patients

Read more
  • Clinical Essentials from Cancer Epidemiol Biomarkers Prev
  • 1 comment

HIV: increased cancer screening may be warranted

Read more
  • Clinical Essentials from National Comprehensive Cancer Network (NCCN)
  • 1 comment

NCCN updates CRC screening guidelines

Read more
  • Clinical Essentials from Eur Urol
  • 1 comment
  • FULLTEXT

Urological cancers: where do checkpoint inhibitors fit in the treatment paradigm?

Read more
  • Clinical Essentials from JAMA Oncol
  • 1 comment

PPI+capecitabine: worse outcomes in gastroesophageal cancer

Read more

Professional Essentials

  • US Professional News
  • FULLTEXT

NPs filling gaps left by physician shortage

Read more
  • US Professional News
  • FULLTEXT

FDA may decrease adverse effects warnings in drug ads

Read more
  • US Professional News
  • FULLTEXT

Do physician-owned hospitals raise or lower costs?

Read more
  • US Professional News
  • FULLTEXT

Nearly all medical residents reside in urban areas

Read more
  • US Professional News
  • FULLTEXT

MBA offers physicians business savvy

Read more
  • US Professional News
  • FULLTEXT

Oklahoma DO charged with murder for opioid deaths

Read more
View more

New in Primary care oncology

  • Clinical Essentials from Am Health Drug Benefits
  • 1 comment
  • FULLTEXT

Prostate cancer: lower CNS risk with abiraterone vs enzalutamide, chemotherapy

Reduced risk for CNS effects was independent of metastases.

Read more
PCV13 vaccine immune response tops PPSV23 in CLL | EHA
  • Conference Essentials
  • 1 comment

PCV13 vaccine immune response tops PPSV23 in CLL | EHA

Immune response superior in 10 out of 12 serotypes after one month.

Read more
  • Clinical Essentials from National Comprehensive Cancer Network
  • 1 comment
  • FULLTEXT

Carcinoid syndrome: NCCN guidelines now include telotristat for persistent diarrhea

Version 3.2017 adds a treatment option for poorly controlled carcinoid syndrome.

Read more
  • Clinical Essentials from J Clin Gastroenterol
  • no comment

HCV DAAs and cancer: is there a link?

Study of 133 patients finds 7 malignancies within 1 y of treatment.

Read more
  • Clinical Essentials from J Clin Oncol
  • 1 comment

Regular NSAID use after CRC diagnosis linked to better survival

Long-term CRC survivors and benefits of NSAID use.

Read more
  • Clinical Essentials from PLoS One
  • no comment
  • FULLTEXT

Thyroid cancer: population study suggests overdiagnosis, overtreatment

Concomitant trends in the incidence, mortality, and surgical treatment of thyroid cancer.

Read more
  • Clinical Essentials from Int J Hematol
  • 1 comment

Direct oral anticoagulants seem safe in patients with myeloproliferative cancers

Small study adds to growing evidence of safety in patients with cancer.

Read more
  • Clinical Essentials from Eur Urol
  • 1 comment
  • FULLTEXT

Prostate cancer: postop PSA does not necessarily predict poor outcomes

PSA persistence after radical prostatectomy predicts poor outcomes only in men with adverse pathology.

Read more
  • Clinical Essentials from BMC Cancer
  • 1 comment
  • FULLTEXT

VTE risk postcurative CRC resection is low

Adjuvant chemotherapy does not increase risk.

Read more
  • Clinical Essentials from Am J Surg
  • 1 comment

Breast cancer testing rates show racial and socioeconomic disparities

NCCN guidelines recommend the ODX for a subset of patients with breast cancer.

Read more
  • Clinical Essentials from Cancer
  • 1 comment

Anal canal cancer is a risk factor for HPV-related second primary cancers

Risk is greatest for patients with a second primary anal cancer.

Read more
  • Clinical Essentials from Surgery
  • 1 comment

Pediatric DTC: low-income patients face treatment delays

This study helps clarify the effect of socioeconomic status on pediatric thyroid cancer outcomes.

Read more
  • Clinical Essentials from Clin Breast Cancer
  • 1 comment

Breast cancer aggressiveness correlates inversely with vitamin D levels

This study adds data to the poorly understood connection between vitamin D deficiency and breast cancer.

Read more
  • Clinical Essentials from Breast Cancer Res Treat
  • 1 comment

Breast cancer prognosis linked to ER status, but only in older women

This study may help clarify the interaction of age and tumor type in breast cancer survival.

Read more